CareDx, Inc (CDNA) Stock Overview
Explore CareDx, Inc’s financial performance, market position, analyst ratings, and future outlook.
CareDx, Inc (CDNA)
Key Financials
Key Financials
Market Cap
2.4B
P/E Ratio
22.27
EPS (TTM)
$0.84
ROE
0.33%
CDNA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of CareDx, Inc (NASDAQ: CDNA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CareDx, Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CDNA on the NASDAQ shows an RSI of 71.12, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $26.99 for the NASDAQ listing.
Key metrics behind CareDx, Inc's NASDAQ-traded stock include a P/E ratio of 22.27 and a market capitalization of 2.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CDNA on the NASDAQ.